Sygehusene i Næstved, Slagelse og Ringsted

Medicin og biovidenskab

1. Denmark 100%
2. Knee Osteoarthritis 90%
3. Randomized Controlled Trials 66%
4. Cohort Studies 57%
5. Knee Replacement Arthroplasties 53%
6. Systematic Reviews 49%
7. Exercise Therapy 46%
8. Asthma 45%
9. Chronic Obstructive Pulmonary Disease 45%
10. Type 2 Diabetes Mellitus 43%
11. Pain 43%
12. Hip Osteoarthritis 42%
13. Exercise 40%
14. Knee 38%
15. Neuromyelitis Optica 35%
16. Osteoarthritis 34%
17. Therapeutics 32%
18. Population 32%
19. Mortality 30%
20. Meta-Analysis 30%
21. Arthroplasty 30%
22. Prospective Studies 29%
23. Hip 28%
24. Pregnancy 28%
25. Child 27%
26. Quality of Life 27%
27. Confidence Intervals 26%
28. Observational Studies 24%
29. Coronavirus 23%
30. Registries 23%
31. Lung 22%
32. Rehabilitation 22%
33. Cardiac Rehabilitation 20%
34. Cross-Sectional Studies 20%
35. Multimorbidity 20%
36. Education 20%
37. Placebos 19%
38. Patient Education 19%
39. Incidence 18%
40. Stroke 18%
41. Comorbidity 17%
42. Health 17%
43. Delivery of Health Care 16%
44. Guidelines 16%
45. Odds Ratio 16%
46. Optic Neuritis 16%
47. Hospital Emergency Service 16%
48. Mothers 16%
49. Suburban Population 16%
50. Multicenter Studies 14%
51. Adrenal Cortex Hormones 14%
52. Referral and Consultation 14%
53. Anti-Bacterial Agents 14%
54. Heart Failure 14%
55. Hypothyroidism 13%
56. Dexamethasone 13%
57. Inflammatory Bowel Diseases 13%
58. Microbiota 12%
59. Neoplasms 12%
60. Acetaminophen 12%
61. Hospitalization 12%
62. Knee Injuries 12%
63. Databases 12%
64. Primary Health Care 12%
65. Fish Oils 12%
66. Hermeneutics 12%
67. Azithromycin 12%
68. Transferrin 12%
69. Lung Neoplasms 12%
70. Idiopathic pulmonary hemosiderosis 12%
71. Magnetic Resonance Imaging 12%
72. Intensive Care Units 11%
73. Feasibility Studies 11%
74. Infections 11%
75. Colorectal Neoplasms 11%
76. Hypersensitivity 11%
77. Chronic Pain 11%
78. Rheumatoid Arthritis 11%
79. Iron 11%
80. Physiologic Monitoring 10%
81. Hypoxia 10%
82. Palliative Care 10%
83. Vitamin D 10%
84. Cost-Benefit Analysis 10%
85. empagliflozin 10%
86. Cardiovascular Diseases 10%
87. Sepsis 9%
88. Tears 9%
89. Crohn Disease 9%
90. Ibuprofen 9%
91. Health Care Outcome Assessment 9%
92. Severe Acute Respiratory Syndrome 9%
93. Parturition 9%
94. Multiple Sclerosis 9%
95. Gastrointestinal Microbiome 9%
96. Caregivers 9%
97. Dyspnea 9%
98. Longitudinal Studies 9%
99. Psoriasis 9%
100. Femoral Nerve 9%